Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens like spironolactone can help treat female-pattern hair loss.

Early treatment is important for better hair regrowth in elderly women with hair loss.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Washing test helps identify hair loss type, low iron levels significant.

Low ferritin and zinc levels, as well as anemia, are linked to more severe hair loss in Egyptian children with chronic hair shedding.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Iron deficiency is linked to hair loss in CTE patients.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

CTE and FPHL are different hair loss types with unique causes.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Low iron and vitamin D are common in young females with hair loss.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.